Report #2864402

Received Oct 8, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 50 yrs
State: UT
Recovered: Unknown
Vaccinated: Sep 9, 2025
Onset: Sep 9, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	5A4H7	—

Symptoms (1)

Product preparation issue

Symptom narrative

Shingrix adjuvant alone administration; Shingrix adjuvant alone administration; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 50-year-old female patient who received Herpes zoster (Shingrix) (batch number 5A4H7, expiry date 23-OCT-2026) for prophylaxis. On 09-SEP-2025, the patient received Shingrix. On 09-SEP-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: Shingrix adjuvant alone administration) and inappropriate dose of vaccine administered (Verbatim: Shingrix adjuvant alone administration). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 22-SEP-2025 The reporter reported that wanted to know how to proceed after administering only the adjuvant portion of Shingrix.